Adusumalli SR, Rawale DG, Thakur K, Purushottam L, Reddy NC, Kalra N, Shukla S, Rai V. “Chemoselective and Site-Selective Lysine Directed Lysine Modification Enables Single?Site Labeling of Native Proteins” Angewandte Chemie IE 2020. DOI: doi.org/10.1002/anie.202000062.
Pant D, Narayanan SP, Vijay N*, Shukla S*. Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer. J of BioSci , 2020, 45(3). DOI: https://doi.org/10.1007/s12038-019-9977-0
Yadav S, Bhagat SD, Gupta A, Samaiya A, Srivastava A, Shukla S*. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer. BMC Cancer, 2019, 19, pp 1031- DOI:https://doi.org/10.1186/s12885-019-6257-1
Single-Site Labeling of Native Proteins Enabled by a Chemoselective and Site-Selective Chemical Technology. Oct 17, 2018. Adusumalli SR, Rawale DG, Singh U, Tripathi P, Paul R, Kalra N, Mishra RK, Shukla S, Rai V. J. Am. Chem. Soc., 2018, 140 (44), pp 15114–15123. DOI: 10.1021/jacs.8b10490
Gupta A, Athira A, Panday RK, Samaiya A, Shukla S*. PAK2-c-MYC-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death & Disease 9: 825 (2018)
Chilamari M, Kalra N, Shukla S, Rai V. Single-site labeling of lysine in proteins through a metal-free multicomponent approach. Chem. Commun., 2018,54, 7302-7305 (2018).
Cell Research- Kornblihtt A. “CTCF: from insulators to alternative splicing regulation”, Cell Research 2012 Mar; 22(3): 450–452.
CCR Connections Vol 6 (1), 2012 “CTCF, a Novel Regulator of Alternative Splicing” https://home.ccr.cancer.gov/connections/dev/2012/Vol6_No1/news_7.asp
Received F1000 article factor (FFa) -17 (exceptional rating) from Faculty of 1000. https://f1000.com/13371987)
US Patent granted: US 8492100 B2
European Patent granted: EP2126578 (Published: Feb 12, 2009)
CSIR: Ref No: 0187NF 2006/1N, filed on Feb 14, 2007; 290DEL 2007